Please wait while we open this resource.
K
Clinical reviews
LEFLUNOMIDE-HYDROXYCHLOROQUINE COMBINATION THERAPY IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (REPURPSS-I): A PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMISED CLINICAL TRIAL
Utrecht University
PDF202011 pages567 KB
The trial enrolled 37 patients who met the classification criteria for primary Sjögren's syndrome, with 21 receiving the combination therapy and 8 receiving a placebo. The study aimed to assess the primary endpoint of efficacy over a 24-week treatment period. The results indicate the potential benefits of this combination therapy in managing symptoms associated with primary Sjögren's syndrome.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology
EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology
IDIOPATHIC INFLAMMATORY MYOPATHIES
Same clinical topic · Rheumatology
MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology
SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology
RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology
RHEUMATOID ARTHRITIS IN ADULTS
Same clinical topic · Rheumatology
BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology
SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology